Literature DB >> 1495939

High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?

M E Sherman1, D Kelly.   

Abstract

The cytologic smears and histopathologic specimens of 18 patients developing cervical intraepithelial neoplasia 3 (CIN3) and two developing invasive squamous carcinoma following the report of at least three negative Papanicolaou tests were studied. A median number of 9.5 smears per patient procured over a median interval of 93.5 mo were reviewed. Twenty-eight (22.7%) of 123 reportedly negative smears revealed a squamous intraepithelial lesion (SIL), 17 (13.8%) were unsatisfactory, 14 (11.4%) lacked an endocervical component, and 37 (30.1%) were classified as atypical squamous cells of undetermined significance (ASQUS) on reexamination. Fourteen (50%) of 28 smears originally misclassified as negative contained fewer than 100 SIL cells and five (17.8%) were severely inflamed. One patient whose smears were misclassified as negative had an atrophic cervix, one had SIL cells primarily in thick sheets, and two had small CIN3 cells resembling squamous metaplasia. Six patients (30%) had a single false negative smear, seven (35%) had multiple false negative smears, seven (35%) had two or more unsatisfactory smears reported as negative, seven had at least two smears lacking an endocervical component, and six had at least two smears taken during pregnancy. Thirteen patients had abnormal smears classified as ASQUS or high-grade SIL (HSIL) but never had a specimen showing only a low-grade SIL (LSIL). This study demonstrates that early signs of SIL may be difficult to recognize cytologically and that poor quality specimens and inadequate sampling may contribute to false negative diagnoses.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1495939

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

1.  Invasive cervical cancer among American Indian women in the Northern Plains, 1994-1998: incidence, mortality, and missed opportunities.

Authors:  Richard F Leman; David Espey; Nathaniel Cobb
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

Review 2.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

3.  [Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

Authors:  P Regitnig; H P Dinges; E Ropp; H Fladerer; F Moinfar; G Breitenecker
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

4.  Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis.

Authors:  Daniel Fontaine; Nadira Narine; Christopher Naugler
Journal:  BMJ Open       Date:  2012-04-13       Impact factor: 2.692

5.  Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark.

Authors:  O Ingemann-Hansen; M Lidang; I Niemann; J Dinesen; U Baandrup; H Svanholm; Lk Petersen
Journal:  Br J Cancer       Date:  2008-03-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.